Research article
Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Ging-Yuek R. Hsiung, A. Dessa Sadovnick and Howard Feldman
CMAJ October 12, 2004 171 (8) 863-867; DOI: https://doi.org/10.1503/cmaj.1031789
Ging-Yuek R. Hsiung
A. Dessa Sadovnick
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
CMAJ
Vol. 171, Issue 8
12 Oct 2004
Article tools
Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Ging-Yuek R. Hsiung, A. Dessa Sadovnick, Howard Feldman
CMAJ Oct 2004, 171 (8) 863-867; DOI: 10.1503/cmaj.1031789
Jump to section
Related Articles
Cited By...
- Effect of APOE {varepsilon}4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD
- EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimers disease
- Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments
- Predictive value of APOE-{varepsilon}4 allele for progression from MCI to AD-type dementia: a meta-analysis
- Joint effect of stroke and APOE 4 on dementia risk: The Canadian Study of Health and Aging
- Conversion to dementia from mild cognitive disorder: the Cache County Study.
- The benefits of apolipoprotein E {epsilon}4 screening to research